[go: up one dir, main page]

BR0115188A - Processo para a preparação de antitrombina iii latente - Google Patents

Processo para a preparação de antitrombina iii latente

Info

Publication number
BR0115188A
BR0115188A BR0115188-6A BR0115188A BR0115188A BR 0115188 A BR0115188 A BR 0115188A BR 0115188 A BR0115188 A BR 0115188A BR 0115188 A BR0115188 A BR 0115188A
Authority
BR
Brazil
Prior art keywords
preparation
antithrombin iii
latent
latent antithrombin
iii
Prior art date
Application number
BR0115188-6A
Other languages
English (en)
Inventor
Goran Karlsson
Original Assignee
Octopharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octopharma Ag filed Critical Octopharma Ag
Publication of BR0115188A publication Critical patent/BR0115188A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE ANTI-TROMBINA III LATENTE". A invenção refere-se a um processo para a preparação de anti-trombina III latente. O processo compreende incubação de uma solução de antitrombina III nativa na presença de íons de sulfato e um tampão selecionado de tampões zwiteriónicos de Good.
BR0115188-6A 2000-11-08 2001-11-08 Processo para a preparação de antitrombina iii latente BR0115188A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (1)

Publication Number Publication Date
BR0115188A true BR0115188A (pt) 2004-02-03

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115188-6A BR0115188A (pt) 2000-11-08 2001-11-08 Processo para a preparação de antitrombina iii latente

Country Status (15)

Country Link
EP (1) EP1332159A1 (pt)
JP (1) JP2004522707A (pt)
KR (1) KR20030057545A (pt)
AU (1) AU2002214468A1 (pt)
BR (1) BR0115188A (pt)
CA (1) CA2428055A1 (pt)
CZ (1) CZ20031277A3 (pt)
EE (1) EE200300218A (pt)
HU (1) HUP0301766A3 (pt)
IL (1) IL155539A0 (pt)
MX (1) MXPA03004030A (pt)
NO (1) NO20032048D0 (pt)
PL (1) PL360410A1 (pt)
RU (1) RU2003117016A (pt)
WO (1) WO2002038610A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
DK1848473T3 (da) 2005-02-07 2013-09-02 Hanuman Llc Plasmakoncentrationsanordning
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
NO20032048L (no) 2003-05-07
MXPA03004030A (es) 2004-02-12
EP1332159A1 (en) 2003-08-06
JP2004522707A (ja) 2004-07-29
WO2002038610A1 (en) 2002-05-16
HUP0301766A3 (en) 2005-12-28
HUP0301766A2 (hu) 2003-08-28
CA2428055A1 (en) 2002-05-16
PL360410A1 (en) 2004-09-06
IL155539A0 (en) 2003-11-23
KR20030057545A (ko) 2003-07-04
AU2002214468A1 (en) 2002-05-21
EE200300218A (et) 2003-08-15
NO20032048D0 (no) 2003-05-07
RU2003117016A (ru) 2004-12-10
CZ20031277A3 (cs) 2003-08-13

Similar Documents

Publication Publication Date Title
BR0115188A (pt) Processo para a preparação de antitrombina iii latente
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
BR0308211A (pt) Cumarinas úteis como biomarcadores
BR0108322A (pt) Caixa de câmbio
EP1446114A4 (en) COMPOSITIONS AND METHODS FOR TREATING OSTEOPOROSIS
HRP20030088A2 (en) Anti-dual integrin antibodies, compositions, methods and uses
BRPI9910332B8 (pt) método para purificação de um polipeptídio a partir de uma composição
BR0116047A (pt) Imidazoquinolinas substituìdas de éter heterocìclico
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
BRPI9915679B8 (pt) composições e métodos para aumentar a mineralização óssea
WO2000023564A3 (en) Protein design automation for protein libraries
BR0012750A (pt) Agente de limpeza para superfìcies cerâmicas vìtreas
BRPI0208456B8 (pt) métodos para cultura de circovírus
PT1087914E (pt) Composicoes de vidro soluvel em agua
AR006776A1 (es) Una composicion en barra
BR9900559A (pt) Composição de vidro de tipo sìlico-sodo-cálcico.
FR2832403B1 (fr) Composition refractaire non faconnee, destinee notamment a la realisation de soles d'un four de verrerie
BR0112380A (pt) Composições de vidro de lìtio
BRPI0415571A (pt) composições de limpeza
BR9608925A (pt) Composição para limpeza e processo para limpeza de sperfícies delicadas
WO2001051651A3 (en) High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam)
SE0004086D0 (sv) Preparation process
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR9911977A (pt) Acilaminofenil-uracilas substituìdas
BR0004578A (pt) Processo de acilação

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]